Lisa Schmidleithner

Lisa Schmidleithner

Auto-generated profile, based on publicly available information

Lisa Schmidleithner

Leibniz Institute for Immunotherapy 1 , Regensburg, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MDMichael Delacher
Michael Delacher
LSLisa Schmidleithner
Lisa Schmidleithner
MSMalte Simon
Malte Simon
PSPhilipp Stüve
Philipp Stüve
LSLieke Sanderink
Lieke Sanderink
MFMarkus Feuerer
Markus Feuerer
CD8 T lymphocytes are classically viewed as cytotoxic T cells. Whether human CD8 T cells can, in parallel, induce a tissue regeneration program is poorly understood. Here, antigen-specific assay systems revealed that human CD8 T cells not only mediated cytotoxicity but also promoted tissue remodeling. Activated CD8 T cells could produce the epidermal growth factor receptor (EGFR)-ligand amphiregulin (AREG) and sensitize epithelial cells for enhanced regeneration potential. Blocking the EGFR or the effector cytokines IFN-γ and TNF could inhibit tissue remodeling. This regenerative program enhanced tumor spheroid and stem cell–mediated organoid growth. Using single-cell gene expression analysis, we identified an AREG+, tissue-resident CD8 T cell population in skin and adipose tissue from patients undergoing abdominal wall or abdominoplasty surgery. These tissue-resident CD8 T cells showed a strong TCR clonal relation to blood PD1+TIGIT+ CD8 T cells with tissue remodeling abilities. These findings may help to understand the complex CD8 biology in tumors and could become relevant for the design of therapeutic T cell products.

29 April 2025 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
LSLisa Schmidleithner
Lisa Schmidleithner
PSPhilipp Stüve
Philipp Stüve
MFMarkus Feuerer
Markus Feuerer

1 July 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
LSLisa Schmidleithner
Lisa Schmidleithner
PSPhilipp Stüve
Philipp Stüve
MFMarkus Feuerer
Markus Feuerer
FOXP3 hijacks DNA-binding proteins to regulate gene expression. In this issue of JEM, He et al. (https://doi.org/10.1084/jem.20232068) propose a dynamic model in which FOXP3 associates with DNA-binding proteins to regulate Treg cell function in response to environmental cues.

3 July 2020 in Nature Immunology
Verified
Journal Article
Open access
PDF file
MBMarc Beyer
Marc Beyer
ZAZeinab Abdullah
Zeinab Abdullah
JCJens M. Chemnitz
Jens M. Chemnitz
DMDaniela Maisel
Daniela Maisel
JSJil Sander
Jil Sander
JSJoachim L. Schultze
Joachim L. Schultze
An amendment to this paper has been published and can be accessed via a link at the top of the paper.